Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

On Thursday 19 April, Oxford University will play host to an AIMday focused on Biomedical Imaging, which is at the heart of much of the clinical and biomedical research conducted at the University.

Following successful AIMdays focusing on Microscopy and Ageing, in April the Divisional Business Development Team will be running an AIMday in Biomedical Imaging, a broad topic which offers the opportunity to discuss the analysis, enhancement and display of images captured via x-ray, ultrasound, MRI, nuclear medicine and optical imaging technologies. A range of companies including GSK, GE Healthcare, Siemens, and Blue Earth Diagnostics are registered to attend, and it is a fantastic chance for researchers looking to network with industry and discuss relevant questions.

AIMdays are a concept which offer a unique way to facilitate interaction between industry and academia. Born at the University of Uppsala in 2008, they have increasingly gathered attention and use at universities across the globe looking to match researchers with industrial partners.

Interested industry partners are invited to submit questions around a certain topic. At the Microscopy AIMday run in Oxford last year, companies including Zeiss, Olympus, and Andor Technology submitted questions around imaging technologies to aid medical diagnostics, use of virtual reality to understand biological processes, and novel techniques for the future of microscopy research.

Academics then choose which of these questions they would like to answer, depending on their particular area of expertise. The AIMday algorithm designs a programme of one-hour sessions that matches industry partners and academics by their shared interests so that sessions can run in parallel, and interaction between industry and academics is maximised. 

Martin Kerr, Business Development Manager and organiser of the AIMday commented: 'AIMdays are a fantastic opportunity for researchers to spark new collaborations, build their networks, and get a fresh perspective on how their work could be translatable. It also offers early stage researchers exposure to the career paths offered by industry.' 

AIMday Biomedical Imaging takes place on Thu 19 April.  Academic registration opens on Mon 26 Feb – find out more and register.

If you would like to find out more about running an AIMday, please contact Martin Kerr

Similar stories

Professor Sir Chris Whitty brings greater understanding of epidemics to Oxford

Chief Medical Officer of England Professor Sir Chris Whitty KCB FMedSci delivers the Sherrington Prize Lecture: Public Understanding of Science to an audience of Oxford staff and students.

The women founders contributing to Oxford’s spinout success

More spinout companies are created by the University of Oxford than any other UK University and an increasing number of their founders and senior leaders are women.

NICE recommends digital mental health technologies from Oxford

Two digital tools were recommended for use in the NHS to help children and young people with symptoms of anxiety or low mood.

Oxford spinout trials revolutionary bioelectronic implant to treat incontinence

The first participants in a clinical trial of a bioelectrical therapy to treat incontinence have received their “smart” bioelectronic implants.

Significant scale-up investment for three Oxford spinouts

Three University of Oxford spinouts have raised significant investment to scale their companies in vehicle automation, quantum computing and medical imaging respectively.

Oxford Innovation Society celebrates pioneering biomedical research and innovation

Last month the Oxford Innovation Society (OIS) hosted an event at Pembroke College which celebrated some of the pioneering translational research and innovation coming out of the University’s Medical Sciences Division.